Posted on August 22, 2022 by Hokkaido NewsACTIV-2d, a global phase 3 trial of novel investigational COVID-19 oral antiviral agent, launches – Medical Xpress ACTIV-2d, a global phase 3 trial of novel investigational COVID-19 oral antiviral agent, launches Medical Xpress
